Trump’s Testimonial Is a Double-Edged Sword for Regeneron
The president raised the drug’s company’s profile by calling its drug a miraculous cure — but also sowed suspicion about whether the treatment really works.
Trump’s Testimonial Is a Double-Edged Sword for Regeneron
The president raised the drug’s company’s profile by calling its drug a miraculous cure — but also sowed suspicion about whether the treatment really works.